Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma

Completed · Phase 1

Conditions studied: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific

In brief

Phase I trial to study the effectivenes of phenylbutyrate in treating adults with refractory solid tumor or lymphoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Key facts

Study ID

NCT00002909

Run by

National Cancer Institute (NCI)

People needed

24

Starts

1997-02-01

Last updated by the study team

2013-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Johns Hopkins Oncology Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.